GCIA
PETX

Gabelli & Co Investment Advisers’s Aratana Therapeutics, Inc. PETX Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-534,397
Closed -$2.76M – 222
2019
Q2 		$2.76M Buy
+534,397
New +$2.4M 0.3% 70

Other funds holding PETX

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Gabelli & Co Investment Advisers's PETX Position: Q3 2019 in Review

Gabelli & Co Investment Advisers sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 534,397 shares — an estimated $2.76M sold.

Gabelli & Co Investment Advisers first reported a position in PETX in Q2 2019 and held it in 1 quarter. The position peaked at $2.76M in Q2 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

  • Gabelli & Co Investment Advisers reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 534,397 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $2.76M.
  • Gabelli & Co Investment Advisers first reported a position in Aratana Therapeutics, Inc. in Q2 2019 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's Aratana Therapeutics, Inc. position peaked at $2.76M in Q2 2019.
  • 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2019, filed 1 Nov 2019.